임상시험 지원 서비스 시장 규모, 점유율, 성장 분석 : 서비스별, 단계별, 시험 디자인별, 적응증별, 스폰서별, 지역별 - 산업 예측(2025-2032년)
Clinical Trials Support Services Market Size, Share, and Growth Analysis, By Service, By Phase, By Study Design, By Indication, By Sponsor, By Region - Industry Forecast 2025-2032
상품코드:1677855
리서치사:SkyQuest Technology Consulting Pvt. Ltd.
발행일:2025년 03월
페이지 정보:영문 219 Pages
라이선스 & 가격 (부가세 별도)
한글목차
임상시험 지원 서비스 2023년 시장 규모는 230억 달러로, 2024년 248억 4,000만 달러에서 2032년에는 459억 8,000만 달러로 확대하며, 예측 기간(2025-2032년)의 CAGR은 8.0%로 성장할 전망입니다.
임상시험 업계는 특히 COVID-19 이후 임상시험, 분석 설계, 지원 서비스에 중점을 두고 괄목할 만한 진화를 이루었습니다. 임상시험용 의약품의 확보 및 보관, 임상시험 시설의 안전 확보, 약물 투여량 계산, 키트 관리 등 필수적인 업무가 이 분야에서 중요한 역할을 하고 있습니다. 특히 2021년 COVID-19 백신 개발 이후 연기되었던 많은 임상시험이 재개되면서 신흥 국가 시장에서 증가하는 만성질환, 전염병, 열대성 질환에 대응하기 위한 혁신적인 의약품에 대한 긴급한 필요성도 부각되고 있습니다. 또한 가상 임상시험으로의 전환이 임상시험 지원 서비스 매출 성장의 주요 원동력으로 부상하고 있으며, 연구 회사들은 임상 연구 방법의 효율성을 높이기 위해 가상 기술 채택을 늘리고 있습니다.
목차
서론
조사의 목적
조사 범위
정의
조사 방법
정보 조달
2차와 1차 데이터 방법
시장 규모 예측
시장의 전제조건과 제한
개요
세계 시장 전망
공급과 수요 동향 분석
부문별 기회 분석
시장 역학과 전망
시장 개요
시장 규모
시장 역학
촉진요인과 기회
억제요인과 과제
Porter의 산업 분석
주요 시장 인사이트
주요 성공 요인
경쟁의 정도
주요 투자 기회
시장 에코시스템
시장의 매력 지수(2024년)
PESTEL 분석
거시경제 지표
밸류체인 분석
가격 분석
임상시험 지원 서비스 시장 규모 : 서비스별 & CAGR(2025-2032)
시장 개요
관리 스탭
임상시험 시설 관리
환자 모집 및 등록 서비스
환자 모집 관리
환자 유지
데이터 관리
기관 심사 위원회
임상시험 지원 서비스 시장 규모 : 단계별 & CAGR(2025-2032)
시장 개요
단계 I
단계 II
단계 III
단계 IV
임상시험 지원 서비스 시장 규모 : 시험 디자인별 & CAGR(2025-2032)
시장 개요
확장 액세스
개입적
관찰적
임상시험 지원 서비스 시장 규모 : 적응증별 & CAGR(2025-2032)
시장 개요
자가면역 또는 염증
심장혈관
당뇨병
종양학
임상시험 지원 서비스 시장 규모 : 스폰서별 & CAGR(2025-2032)
시장 개요
의료기기
의약품·바이오의약품
임상시험 지원 서비스 시장 규모 : 지역별 & CAGR(2025-2032)
북미
미국
캐나다
유럽
독일
스페인
프랑스
영국
이탈리아
기타 유럽 지역
아시아태평양
중국
인도
일본
한국
기타 아시아태평양
라틴아메리카
브라질
기타 라틴아메리카 지역
중동 및 아프리카
GCC 국가
남아프리카공화국
기타 중동 및 아프리카
경쟁 정보
상위 5사의 비교
주요 기업의 시장 포지셔닝(2024년)
주요 시장 기업이 채택한 전략
최근 시장 동향
기업의 시장 점유율 분석(2024년)
주요 기업의 기업 개요
기업의 상세
제품 포트폴리오 분석
기업의 부문별 점유율 분석
매출의 전년대비 비교(2022-2024)
주요 기업 개요
Laboratory Corporation of America Holdings(LabCorp)(USA)
Charles River Laboratories International, Inc.(USA)
Syneos Health, Inc.(USA)
Parexel International Corporation(USA)
ICON plc(Ireland)
Wuxi AppTec Co., Ltd.(China)
Eurofins Scientific(Luxembourg)
ACM Global Laboratories(USA)
Clinipace Worldwide(USA)
Worldwide Clinical Trials(USA)
Premier Research(USA)
PSI CRO AG(Switzerland)
Novotech(Australia)
Velocity Clinical Research(USA)
Fortrea(USA)
CTI Clinical Trial and Consulting Services(USA)
결론과 제안
KSA
영문 목차
영문목차
Clinical Trials Support Services Market size was valued at USD 23.0 billion in 2023 and is poised to grow from USD 24.84 billion in 2024 to USD 45.98 billion by 2032, growing at a CAGR of 8.0% during the forecast period (2025-2032).
The clinical trials industry has witnessed significant evolution, particularly post-pandemic, with an emphasis on clinical testing, assay design, and support services. Essential operations such as securing and storing research medications, safeguarding trial sites, calculating drug dosages, and managing kits play a vital role in this domain. The resurgence of numerous postponed trials, particularly after the development of COVID-19 vaccines in 2021, has also highlighted the urgent need for innovative pharmaceuticals to address rising chronic, infectious, and tropical diseases in emerging markets. Additionally, the shift towards virtual clinical trials has emerged as a key driver of revenue growth in clinical trial support services, as research firms increasingly adopt virtual technologies to enhance the efficiency of their clinical research processes.
Top-down and bottom-up approaches were used to estimate and validate the size of the Clinical Trials Support Services market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Clinical Trials Support Services Market Segments Analysis
Global Clinical Trials Support Services Market is segmented by Service, Phase, Study Design, Indication, Sponsor and region. Based on Service, the market is segmented into Administrative Staff, Clinical Trial Site Management, Data Management and Institutional Review Boards. Based on Phase, the market is segmented into Phase I, Phase II, Phase III and Phase IV. Based on Study Design, the market is segmented into Expanded Access, Interventional and Observational. Based on Indication, the market is segmented into Autoimmune or Inflammation, Cardiovascular, Diabetes and Oncology. Based on Sponsor, the market is segmented into Medical Devices and Pharmaceutical & Biopharmaceutical. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
Driver of the Clinical Trials Support Services Market
The growth of the Clinical Trials Support Services market is primarily driven by several key factors, including the increasing prevalence of infectious and chronic diseases, which necessitates extensive research efforts. Additionally, pharmaceutical companies are investing significantly in research and development, further fueling market expansion. The rise of contract research organizations (CROs) is also contributing to this trend, as they offer specialized expertise and resources for conducting clinical trials. Furthermore, the escalating demand for clinical trials in emerging markets is creating new opportunities, ultimately driving the overall growth and evolution of the Clinical Trials Support Services landscape.
Restraints in the Clinical Trials Support Services Market
The growth of the Clinical Trials Support Services market is hindered by insufficient medical infrastructure and advanced technological equipment. Moreover, strict regulations surrounding patient recruitment and the absence of robust management frameworks for the trials pose significant challenges to the market's overall development. However, there remains a promising opportunity for growth driven by the globalization of clinical trials and continuous advancements in technology resulting from ongoing research and development efforts. Addressing these constraints could pave the way for a more dynamic market environment, fostering innovation and improving the efficiency of clinical trial processes.
Market Trends of the Clinical Trials Support Services Market
The Clinical Trials Support Services market is poised for significant growth due to several key trends. The increasing demand for clinical trials in emerging nations, propelled by improved regulatory frameworks and healthcare infrastructure, is driving expansion. Additionally, rising research and development (R&D) investments from pharmaceutical companies, largely fueled by patent expirations, are escalating the need for efficient trial execution. The proliferation of contract research organizations (CROs) further enhances this trend, as they offer specialized services that streamline the trial process and reduce costs. Collectively, these factors indicate a robust and rapidly expanding global market for clinical trials support services.
Table of Contents
Introduction
Objectives of the Study
Scope of the Report
Definitions
Research Methodology
Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations
Executive Summary
Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis
Market Dynamics & Outlook
Market Overview
Market Size
Market Dynamics
Drivers & Opportunities
Restraints & Challenges
Porters Analysis
Competitive rivalry
Threat of substitute
Bargaining power of buyers
Threat of new entrants
Bargaining power of suppliers
Key Market Insights
Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2024
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis
Global Clinical Trials Support Services Market Size by Service & CAGR (2025-2032)
Market Overview
Administrative Staff
Clinical Trial Site Management
Patient Recruitment & Registry Services
Patient Recruitment Management
Patient Retention
Data Management
Institutional Review Boards
Global Clinical Trials Support Services Market Size by Phase & CAGR (2025-2032)
Market Overview
Phase I
Phase II
Phase III
Phase IV
Global Clinical Trials Support Services Market Size by Study Design & CAGR (2025-2032)
Market Overview
Expanded Access
Interventional
Observational
Global Clinical Trials Support Services Market Size by Indication & CAGR (2025-2032)
Market Overview
Autoimmune or Inflammation
Cardiovascular
Diabetes
Oncology
Global Clinical Trials Support Services Market Size by Sponsor & CAGR (2025-2032)
Market Overview
Medical Devices
Pharmaceutical & Biopharmaceutical
Global Clinical Trials Support Services Market Size & CAGR (2025-2032)
North America (Service, Phase, Study Design, Indication, Sponsor)
US
Canada
Europe (Service, Phase, Study Design, Indication, Sponsor)
Germany
Spain
France
UK
Italy
Rest of Europe
Asia Pacific (Service, Phase, Study Design, Indication, Sponsor)
China
India
Japan
South Korea
Rest of Asia-Pacific
Latin America (Service, Phase, Study Design, Indication, Sponsor)
Brazil
Rest of Latin America
Middle East & Africa (Service, Phase, Study Design, Indication, Sponsor)
GCC Countries
South Africa
Rest of Middle East & Africa
Competitive Intelligence
Top 5 Player Comparison
Market Positioning of Key Players, 2024
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2024
Company Profiles of All Key Players
Company Details
Product Portfolio Analysis
Company's Segmental Share Analysis
Revenue Y-O-Y Comparison (2022-2024)
Key Company Profiles
Laboratory Corporation of America Holdings (LabCorp) (USA)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
Charles River Laboratories International, Inc. (USA)
